GeoPolitics Pulse

The Heartbeat of World events

Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC

by ·

European Commission approves Mirum’s LIVMARLI for PFIC in young patients, highlighting significant clinical benefits and positive trial results.Read More